Mitchell Hill

Array ( [id] => 4288086 [patent_doc_number] => 06268343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Derivatives of GLP-1 analogs' [patent_app_type] => 1 [patent_app_number] => 9/258750 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 0 [patent_no_of_words] => 208262 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268343.pdf [firstpage_image] =>[orig_patent_app_number] => 258750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450343 [patent_doc_number] => 06455499 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Methods for treating disorders associated with LHRH activity' [patent_app_type] => B1 [patent_app_number] => 09/256599 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16337 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455499.pdf [firstpage_image] =>[orig_patent_app_number] => 09256599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297829 [patent_doc_number] => 06184345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Branched building units for synthesizing cyclic peptides' [patent_app_type] => 1 [patent_app_number] => 9/246567 [patent_app_country] => US [patent_app_date] => 1999-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13536 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184345.pdf [firstpage_image] =>[orig_patent_app_number] => 246567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1250081 [patent_doc_number] => 06675105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors' [patent_app_type] => B2 [patent_app_number] => 09/245764 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 241845 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/675/06675105.pdf [firstpage_image] =>[orig_patent_app_number] => 09245764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000841 [patent_doc_number] => 20020028912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'CHEMICALLY MODIFIED POLYPEPTIDES' [patent_app_type] => new [patent_app_number] => 09/230733 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028912.pdf [firstpage_image] =>[orig_patent_app_number] => 09230733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550407 [patent_doc_number] => 06346601 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Procedure for obtaining the somatostatin analog, octreotide' [patent_app_type] => B1 [patent_app_number] => 09/240145 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3103 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346601.pdf [firstpage_image] =>[orig_patent_app_number] => 09240145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272767 [patent_doc_number] => 06307090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Acylated oligopeptide derivatives having cell signal inhibiting activity' [patent_app_type] => 1 [patent_app_number] => 9/236160 [patent_app_country] => US [patent_app_date] => 1999-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 26454 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307090.pdf [firstpage_image] =>[orig_patent_app_number] => 236160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262146 [patent_doc_number] => 06204365 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Collagen modulators for use in photoablation eximer laser keratectomy' [patent_app_type] => 1 [patent_app_number] => 9/232529 [patent_app_country] => US [patent_app_date] => 1999-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 38 [patent_no_of_words] => 9926 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204365.pdf [firstpage_image] =>[orig_patent_app_number] => 232529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176553 [patent_doc_number] => 06084066 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Polypetides that include conformation-constraining groups which flank a protein-protein interaction site' [patent_app_type] => 1 [patent_app_number] => 9/231797 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18509 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/084/06084066.pdf [firstpage_image] =>[orig_patent_app_number] => 231797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370307 [patent_doc_number] => 06288029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Template associated NPY Y2-receptor agonists' [patent_app_type] => 1 [patent_app_number] => 9/229900 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 9767 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288029.pdf [firstpage_image] =>[orig_patent_app_number] => 229900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486902 [patent_doc_number] => 06428812 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Process for producing granules containing angiotensin-converting enzyme inhibiting peptides' [patent_app_type] => B1 [patent_app_number] => 09/231449 [patent_app_country] => US [patent_app_date] => 1999-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 3115 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428812.pdf [firstpage_image] =>[orig_patent_app_number] => 09231449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745695 [patent_doc_number] => 20030022878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'TELOMERASE INHIBITOR' [patent_app_type] => new [patent_app_number] => 09/221931 [patent_app_country] => US [patent_app_date] => 1998-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4567 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022878.pdf [firstpage_image] =>[orig_patent_app_number] => 09221931 [rel_patent_id] =>[rel_patent_doc_number] =>)